DEVICE GUIDE > Self-Expanding Stent Grafts

Company Name Product Name Materials Used Introducer Size (F) Endhole (inch) Stent Diameter (mm) Stent Length (mm) Delivery System Length (cm) US FDA Indicated Use Footnotes
Bard Peripheral Vascular, Inc. Flair Endovascular Stent Graft Nitinol/ePTFE 9 0.035 6, 7, 8,* 9* 30, 40, 50, 70 80 Indicated for use in the treatment of stenoses at venous anastomosis of ePTFE or other synthetic AV grafts *8-, 9-mm diameter not available on 70-mm length
Bard Peripheral Vascular, Inc. Fluency Plus Endovascular Stent Graft Nitinol/ePTFE 8, 9, 10 0.035 6, 7, 8, 9, 10, 12, 13.5 40, 60, 80, 100, 120 80, 117 Indicated for use in the treatment of in-stent restenosis in the venous outflow of hemodialysis patients dialyzing by either an AVF or AV graft and for the treatment of stenosis in the venous outflow of hemodialysis patients dialyzing by an AV graft
Boston Scientific Corporation Wallgraft Tracheobronchial Endoprothesis Elgiloy plus PTE 9 (up to 8 X 70 mm), 10 (up to 10 X 70 mm), 11 (up to 12 X 70 mm), 12 (up to 14 X 70 mm) 0.035 6, 7, 8, 9, 10, 12, 14 20, 30, 50, 70 90 Tracheobronchial
Gore & Associates Gore Viabahn Endoprosthesis Nitinol/ePTFE, gold 7–12 0.035 5, 6, 7, 8, 9, 10, 11, 13 25, 50, 100, 150 75, 120 5–8 mm indicated for SFA lesions up to 270 mm in length; 5–7 mm indicated for in-stent restenosis lesions in SFA up to 270 mm in length; 5–13 mm indicated for iliac artery lesions up to 80 mm in length; also indicated for stenosis or thrombotic occlusion at venous anastomosis of AV access grafts
Gore & Associates Gore Viabahn Endoprosthesis With Heparin Bioactive Surface Nitinol/ePTFE, gold 6–12 0.018/0.014 (5–8 mm), 0.035 (5–13 mm) 5, 6, 7, 8, 9, 10, 11, 13 25, 50, 75, 100, 150, 250 75 (0.035-inch system only), 120 5–8 mm indicated for SFA lesions up to 270 mm in length; 5–7 mm indicated for in-stent restenosis lesions in SFA up to 270 mm in length; 5–13 mm indicated for iliac artery lesions up to 80 mm in length; also indicated for stenosis or thrombotic occlusion at venous anastomosis of AV access grafts
Gore & Associates Gore Viabil Biliary Endoprosthesis Nitinol/ePTFE 10 percutaneous 0.035 8, 10 40, 60, 80, 100 40 percutaneous Malignant biliary strictures* *Contraindicated for all cardiovascular applications
Gore & Associates Gore Viatorr TIPS Endoprosthesis Nitinol/ePTFE 10 0.038 8, 10, 12 60, 70, 80, 90, 100 75 TIPS, tracheobronchial TIPS, transjugular intrahepatic portosystemic shunt

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.